Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
16 16 Search
2025
Targeting hypoxia-induced HIF-1α/JMJD3/Notch axis in gastric cancer therapy
Journal of Bioenergetics and Biomembranes
2024
Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022
Frontiers in Oncology
2024
Mesenchymal stem cell-derived exosomal microRNA-367-3p mitigates lower limb ischemia/reperfusion injury in mouse skeletal muscle via EZH2 targeting
Journal of Pharmacy and Pharmacology
2024
Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression
American Journal of Physiology-Cell Physiology
2023
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer
Molecular Cancer
2023
A novel molecular classification method for osteosarcoma based on tumor cell differentiation trajectories
Bone Research
2023
Epigenetic Cancer Therapy
2022
Epigenetic Drugs and Their Immune Modulating Potential in Cancers
Biomedicines
2022
The Immunohistochemical Loss of H3K27me3 in Intracranial Meningiomas Predicts Shorter Progression-Free Survival after Stereotactic Radiosurgery
Cancers
2022
[Retracted] EZH2 Regulates ANXA6 Expression via H3K27me3 and Is Involved in Angiotensin II‐Induced Vascular Smooth Muscle Cell Senescence
Oxidative Medicine and Cellular Longevity
2022
H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma
Biomedicines
2022
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Journal of Hematology & Oncology
2022
Long non‐coding RNA SNHG16 decreased SMAD4 to induce gemcitabine resistance in pancreatic cancer via EZH2‐mediated epigenetic modification
The Kaohsiung Journal of Medical Sciences
2021
Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma
BMC Cancer
2021
Significance of KDM6A mutation in bladder cancer immune escape
BMC Cancer
2020
EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer
Cancer Cell International